How a Fertility Practice Turned a Broken Lead Pipeline Into 1,170% ROI
Estimated Read Time: 3 minutes
In 2022, a regional fertility practice in the Southeastern U.S. was averaging 130 leads a month. Most of them went nowhere. Procedure volume was declining, staff turnover kept disrupting the patient experience, and national competitors with bigger ad budgets were moving into the market. The practice did not need more marketing. It needed someone to close the gap between patient interest and a booked appointment.
That gap is where most fertility practices lose revenue, and it is rarely the marketing that is the problem.
The Real Bottleneck: Lead Loss, Not Lead Generation
A pre-partnership audit of this practice's pipeline, run January through May 2023, told the real story. Only 19% of leads became a qualified opportunity. Just 15% of those opportunities turned into a scheduled consult. Patients who did move forward waited an average of 132 days, more than four months, before paying a treatment deposit.
Nationally, healthcare providers lose an estimated 81% of marketing leads before they ever convert to a patient. That is not a marketing spend problem. It is a follow-up and qualification problem, and it is the exact gap Care Sherpa was built to close.
What Changed
Care Sherpa took over the practice's lead engagement, patient qualification, and appointment access, then added ongoing quality monitoring to keep the process improving. Instead of leads sitting in a queue waiting for a callback, Sherpas responded in minutes, assessed clinical and financial readiness, and guided patients directly to a scheduled consult.
The practice also had a digital identity problem: unclaimed listings, duplicate profiles, and no consistent presence across the platforms where prospective patients were actually searching. Fixing that was one of the first priorities of the partnership, not an afterthought.
The Results
Within three years, the numbers moved in a direction most fertility practices only aspire to.
Lead volume grew 4.1X compared to the historical baseline. Monthly consults increased 173%. The average time from first contact to paid deposit dropped by 42 days, from 132 days down to under 90.
The more important shift was in the mix of patients converting. High-value procedures, including IVF, INVOcell, and frozen embryo transfer, grew from 55% of completed procedures to 79%. High-value leads converted at over 60%, roughly double the practice's overall funnel performance and well above typical benchmarks for elective fertility care.
Care Sherpa paid for itself in month three. By year three, the partnership was returning $12.70 for every $1 invested: a 1,170% ROI. You can see the full metrics and partnership timeline in the complete case study.
“You are the employee that I never have to worry about. Care Sherpa shows up every day, you never complain, and you always perform.”
Why This Matters Beyond Fertility
Fertility care sits at the intersection of high emotional stakes and high-cost decisions, which makes it one of the harder specialties to convert leads in. If a rapid-response, qualification-first model can move conversion rates this much in that environment, the same approach applies to any elective specialty where patients need guidance and not just a phone call: cosmetic surgery, weight loss procedures, orthopedics, and other high-consideration services. It's the same gap we broke down in why an AI scheduling tool alone won't convert patients , technology can generate the interest, but someone still has to close the loop.
The providers who close this gap are not spending more on marketing. They are making sure the leads they already have do not disappear before reaching the front desk.
Care Sherpa partners with healthcare providers to close the gap between patient interest and appointment completion. We combine personalized AI, intelligent automation, and live-agent concierge services to guide new patients from first contact through the door.